Anti-Th2 cytokines inhibit progression in a murine model of childhood asthma

J. Siegle, N. Hansbro, C. Dong, P. Angkasekwinai, P. Foster, R. Kumar (Sydney, Newcastle, Australia; Houston, United States Of America; Pathumthani, Thailand)

Source: Annual Congress 2010 - Animal models of asthma and lung inflammation
Session: Animal models of asthma and lung inflammation
Session type: Thematic Poster Session
Number: 1342
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Siegle, N. Hansbro, C. Dong, P. Angkasekwinai, P. Foster, R. Kumar (Sydney, Newcastle, Australia; Houston, United States Of America; Pathumthani, Thailand). Anti-Th2 cytokines inhibit progression in a murine model of childhood asthma. Eur Respir J 2010; 36: Suppl. 54, 1342

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The roles of Th2 cytokines and their signaling pathways in the pathogenesis of non-eosinophilic asthma enhanced by dsRNA
Source: Annual Congress 2006 - Immunological mechanisms in cell recruitment to the lungs
Year: 2006


Targeting PI3Kd attenuates influenza virus-induced inflammation in a murine model of asthma exacerbation
Source: International Congress 2017 – Infection and exacerbation science
Year: 2017

Role of CD163 in human fatal asthma and murine asthma model.
Source: International Congress 2018 – Physiological and biological insights in asthma
Year: 2018

Corticosteroids prevent airway remodeling in a mouse model of chronic asthma through TGF-β signaling
Source: Eur Respir J 2006; 28: Suppl. 50, 225s
Year: 2006

B cells in different stages of development increase in the lung in a murine model of airway allergic inflammation
Source: Annual Congress 2009 - Animal models of airways inflammation
Year: 2009


IL-17 and Th17-cells as markers of disease progression in pediatric allergic diseases. A therapeutic approach in an "in vitro" models
Source: Annual Congress 2011 - T-cell subsets
Year: 2011


Murine models of asthma
Source: Eur Respir J 2003; 22: 374-382
Year: 2003



Hsp90 binding inhibitors improve survival in a murine model of sepsis induced acute lung injury
Source: Annual Congress 2006 - Novel pathogenic aspects of acute lung injury and acute respiratory distress syndrome (ARDS)
Year: 2006


Aerobic training decreases epithelial expression of Th2 cytokines in a murine model of allergic lung inflammation
Source: Annual Congress 2007 - Towards an understanding of asthma pathogenesis - novel in vitro assays and results from animal models
Year: 2007


Osteopontin blockade prevents fibrosis in a murine chronic model of allergic airway disease
Source: Eur Respir J 2007; 30: Suppl. 51, 60s
Year: 2007

IL-22 and its receptors are increased in human and experimental COPD and contribute to pathogenesis
Source: Eur Respir J, 54 (1) 1800174; 10.1183/13993003.00174-2018
Year: 2019



Obesity enhances allergen-induced airway inflammation in a murine model of asthma
Source: International Congress 2019 – Modelling and monitoring of airway diseases
Year: 2019

Decreased Smad7 expression in the airways of a mouse model of chronic asthma
Source: Annual Congress 2004 - Animal models of allergic airway disease
Year: 2004


Genetic deletion of SLPI promotes inflammatory cell recruitment in a model of chronic lung disease
Source: Virtual Congress 2021 – Emerging new mechanisms of chronic lung disease
Year: 2021


CpG oligodeoxynucleotide treatment prevents the development of airway remodelling in a murine model of chronic asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 2s
Year: 2002

IL-13-dependent C3a-release in a murine model of allergic asthma
Source: Annual Congress 2005 - Airway epithelial cells in asthma and COPD
Year: 2005


MIF antagonism restores corticosteroid sensitivity in a murine model of severe asthma
Source: International Congress 2018 – Identification of therapeutic targets for asthma
Year: 2018

LATE-BREAKING ABSTRACT: The histone-deacetylase-8 selective inhibitor PCI-34051 enhances IFN-λ production in vitro and reduces inflammation in mouse models of rhinoviral infection and rhinovirus-induced exacerbations of asthma in vivo
Source: Annual Congress 2013 –Hot topics on airway diseases: new horizons in treatment
Year: 2013

Opioid-neurotensin hybrid influences pulmonary inflammatory process in murine model of non-atopic asthma.
Source: International Congress 2017 – Towards better treatments for lung disease: experimental pharmacology
Year: 2017

Plasma cells in the airways express neurotrophins and neurotrophin-receptors in a mouse model of chronic allergic asthma
Source: Annual Congress 2007 - Regulation of allergic airway inflammation in animal models of asthma
Year: 2007